<bill session="114" type="h" number="2241" updated="2019-02-06T19:37:22Z">
  <state datetime="2015-12-18T09:50:39-05:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2015-12-18T09:50:39-05:00"/>
  </status>
  <introduced datetime="2015-05-05"/>
  <titles>
    <title type="short" as="introduced">Global Health Innovation Act of 2015</title>
    <title type="short" as="passed house">Global Health Innovation Act of 2015</title>
    <title type="official" as="introduced">To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.</title>
    <title type="display">Global Health Innovation Act of 2015</title>
  </titles>
  <sponsor bioguide_id="S001165"/>
  <cosponsors>
    <cosponsor bioguide_id="C001084" joined="2015-11-05"/>
    <cosponsor bioguide_id="C001078" joined="2015-07-28"/>
    <cosponsor bioguide_id="C001045" joined="2015-07-09"/>
    <cosponsor bioguide_id="D000617" joined="2015-07-22"/>
    <cosponsor bioguide_id="D000600" joined="2015-05-05"/>
    <cosponsor bioguide_id="D000625" joined="2015-11-04"/>
    <cosponsor bioguide_id="E000179" joined="2015-11-04"/>
    <cosponsor bioguide_id="G000553" joined="2015-07-23"/>
    <cosponsor bioguide_id="G000551" joined="2015-09-30"/>
    <cosponsor bioguide_id="H001038" joined="2015-11-04"/>
    <cosponsor bioguide_id="K000375" joined="2015-11-04"/>
    <cosponsor bioguide_id="L000582" joined="2015-09-30"/>
    <cosponsor bioguide_id="M001143" joined="2015-12-08"/>
    <cosponsor bioguide_id="M001137" joined="2015-07-09"/>
    <cosponsor bioguide_id="M001188" joined="2015-11-04"/>
    <cosponsor bioguide_id="P000096" joined="2015-11-04"/>
    <cosponsor bioguide_id="R000578" joined="2015-11-16"/>
    <cosponsor bioguide_id="R000435" joined="2015-05-12"/>
    <cosponsor bioguide_id="S000344" joined="2015-11-04"/>
    <cosponsor bioguide_id="S000522" joined="2015-10-28"/>
    <cosponsor bioguide_id="S001187" joined="2015-09-30"/>
  </cosponsors>
  <actions>
    <action datetime="2015-05-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-05-05" state="REFERRED">
      <text>Referred to the House Committee on Foreign Affairs.</text>
    </action>
    <action datetime="2015-11-05">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2015-11-05" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Unanimous Consent.</text>
    </calendar>
    <action datetime="2015-12-16T11:46:07-05:00">
      <text>Mr. Royce moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2015-12-16T11:46:27-05:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H9348-9349" label="consideration"/>
      <reference ref="CR H9348" label="text of measure as introduced"/>
    </action>
    <action datetime="2015-12-16T11:46:29-05:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 2241.</text>
    </action>
    <action datetime="2015-12-16T11:54:00-05:00">
      <text>At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Royce objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.</text>
    </action>
    <action datetime="2015-12-18T09:49:57-05:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H10696" label="consideration"/>
    </action>
    <vote how="by voice vote" type="vote" datetime="2015-12-18T09:50:39-05:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR 12/16/2015 H9348" label="text"/>
    </vote>
    <action datetime="2015-12-18T09:50:46-05:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2015-12-18">
      <text>Received in the Senate and Read twice and referred to the Committee on Foreign Relations.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFR" name="Senate Foreign Relations" activity="Referral"/>
    <committee subcommittee="" code="HSFA" name="House Foreign Affairs" activity="Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="International affairs"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Foreign aid and international relief"/>
    <term name="HIV/AIDS"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Product development and innovation"/>
    <term name="Public-private cooperation"/>
    <term name="U.S. Agency for International Development (USAID)"/>
    <term name="Women's health"/>
    <term name="World health"/>
  </subjects>
  <amendments/>
  <summary date="2015-12-18T14:43:28Z" status="Passed House amended">Global Health Innovation Act of 2015

(Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding:

 the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations; how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; how goals are set for health product development in relation to USAID's health-related goals; how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline; how USAID is coordinating with other federal departments and agencies in support of global health product development; and how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.</summary>
  <committee-reports/>
</bill>
